Riverbridge Partners LLC Cuts Stock Holdings in Danaher Corporation $DHR

Riverbridge Partners LLC cut its stake in Danaher Corporation (NYSE:DHR) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 240,606 shares of the conglomerate’s stock after selling 9,641 shares during the period. Riverbridge Partners LLC’s holdings in Danaher were worth $55,080,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. JPL Wealth Management LLC purchased a new stake in Danaher during the 3rd quarter worth about $25,000. WFA of San Diego LLC purchased a new position in shares of Danaher in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new position in shares of Danaher during the second quarter worth about $27,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Danaher during the third quarter worth about $27,000. Finally, TruNorth Capital Management LLC purchased a new stake in shares of Danaher during the third quarter worth approximately $28,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their target price on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Guggenheim increased their price objective on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, January 2nd. Robert W. Baird set a $251.00 price objective on shares of Danaher in a report on Thursday, January 29th. Jefferies Financial Group lifted their price objective on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, KeyCorp reissued an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Nineteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $253.55.

Danaher Stock Up 0.5%

DHR stock opened at $188.13 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $242.80. The company’s 50 day moving average is $210.39 and its two-hundred day moving average is $214.52. The stock has a market cap of $133.03 billion, a P/E ratio of 37.33, a PEG ratio of 2.54 and a beta of 0.93.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.14 EPS. Research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be paid a $0.40 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, March 27th. Danaher’s payout ratio is currently 25.40%.

Insider Activity

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.